UCL publishes independent report into regenerative medicine research

The outcome of the independent special inquiry into regenerative medicine research at UCL, instigated by the UCL Vice-Provost (Research), has been published today. It investigated UCL's involvement in regenerative medicine research with a particular focus on UCL's relationship to Professor Paolo Macchiarini and the Karolinska Institute. The inquiry has made a series of recommendations and UCL will act upon all of them. We are grateful to the panel for their work. The recommendations include: reporting the inquiry findings to the Medicines and Healthcare products Regulatory Agency (MHRA) and the Karolinska Institute, and collaborating with relevant bodies in further investigations. improving the training and support of our staff and students to ensure compliance with regulations pertaining to the clinical use of biomedical devices, and taking steps to clarify and standardise our policies and practices. ensuring that research misconduct investigations are completed in a timely manner and that we are transparent in communicating allegations and findings of investigations, including the assurance that funders are well-informed and that studies are not subject to unnecessary delays.